In summary, combined treatment using a 90Y-labeled fully human anti-CD147 antibody 059-053 with gemcitabine significantly suppressed tumor growth and prolonged survival in a BxPC-3 xenograft mouse model of refractory pancreatic cancer. Here, BSG is linked to pancreatic neoplasm.